Categories Earnings, Industrials

Globus Maritime reports a decline in Q1 revenue

Shipping company Globus Maritime (Nasdaq: GLBS) reported its Q1 2019 results after the market close. Globus Maritime’s comprehensive loss for the first quarter of 2019 narrowed to $0.5 million or $0.15 basic loss per share from a loss of $1.5 million or $0.48 basic loss per share for the same period last year. Revenue decreased to $3.5 million for the quarter ended March 31, 2019, from $3.9 million in the prior-year quarter.

“This has been a very precarious first quarter where rates in the dry bulk sector have taken an unexpected dive. We do see several factors that might have contributed to that, such as lower seasonal demand, weather disruptions in Australia and the Vale dam failure. Undoubtedly, weak rates have had a negative impact on the hiring of our vessels that were operating on the spot market during the quarter,” said Athanasios Feidakis, CEO and CFO of Globus Maritime.

He also added that the company expects rates to improve in the latter part of the year, mainly due to continuous demand from China for dry bulk goods and the IMO 2020 regulations.

Globus Maritime stock whipsawed higher and lower during the after-hours and finally settled in the negative territory. Post hitting the 52-week high ($11.90) in early November, the stock plunged to a 52-week low ($2.46) on December 27, 2018. Shares of Globus ended today’s session at $2.92, up 1.39%.

Globus Maritime stock had increased 5% since the beginning of this year and dropped 57% in the past 52 weeks.

We’re on Apple News! Follow us to receive the latest stock market, earnings and financial news at your fingertips

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top